Entities linked to Aveanna Healthcare Holdings Inc. director Paul R. Vigano sold approximately $192.6 million in company stock in a two-day block trade executed on August 20 and 21, 2026.
The transactions were conducted at a fixed price of $11.50 per share across all entities involved. On August 20, J.H. Whitney VII, L.P. sold 10.11 million shares for $116.3 million, while PSA Healthcare Investment Holding LLC disposed of 957,918 shares for $11.0 million. Additional sales that day included 1.81 million shares by JHW Iliad Holdings LLC and 1.43 million shares by PSA Iliad Holdings LLC, totaling $20.9 million and $16.4 million respectively. JHW Iliad Holdings II, LLC sold 190,130 shares for $2.2 million. On August 21, PSA Healthcare Investment Holding LLC sold an additional 2.25 million shares for $25.9 million under an option tied to an underwritten secondary offering.
Following the sales, Aveanna Healthcare’s stock price rose to $13.70, a near 19% increase from the $11.50 sale price. The shares had previously reached a 52-week high of $13.98. Over the past year, the stock has delivered an 83% return, with a 94% gain recorded over the last six months. InvestingPro analysis currently flags the stock as overvalued relative to its fair value estimate.
Paul R. Vigano, a managing member of Equity Partners VII and a senior managing director at Capital Partners, holds an indirect ownership stake in the disposing entities. He disclaims beneficial ownership beyond his pecuniary interest. After the transactions, PSA Healthcare Investment Holding LLC retained 12.32 million shares indirectly, while other entities reported no remaining beneficial ownership.
Aveanna Healthcare reported Q2 2026 revenue of $670.5 million, exceeding the $638.6 million forecast and rising 13.7% year-over-year. The company raised its full-year outlook following the results, with EBITDA exceeding expectations by 16%. Analysts have also revised price targets upward: Raymond James increased its target to $15.00 from $13.00 with a Strong Buy rating, while RBC Capital raised its target to $16.00 from $10.00, citing an upcoming California private duty nursing rate increase scheduled for January 2027. The secondary offering involved 15 million shares of common stock by selling stockholders, with underwriters holding a 30-day option to purchase an additional 2.25 million shares.
